Please login to the form below

Not currently logged in
Email:
Password:

GSK to operate lab service for 2012 Games

GlaxoSmithKline (GSK) will provide facilities and equipment to implement anti-doping plans at the 2012 Olympic and Paralympic Games

GlaxoSmithKline (GSK) will provide facilities and equipment to implement anti-doping plans at the 2012 Olympic and Paralympic Games. The London Organising Committee of the Games made the announcement today.

GSK will be the official laboratory services provider in a tier three deal, with GSK providing the facilities to enable King's College London to operate a World Anti-Doping Agency (WADA)  accredited satellite laboratory at the Games.

Thousands of samples will be analysed, with the laboratory in operation 24 hours a day.

Andrew Witty, CEO of GSK said: "The Olympic Games and Paralympic Games provide GSK with a huge opportunity to be part of the delivery of an outstanding world event.

"I'm delighted we've put this alliance with King's College London together to ensure that excellent science can play a key role in ensuring the Games are conducted to the highest ethical standards and that athletes can lead healthier lives. The Olympic and Paralympic ideals of people striving to achieve their best are core to those of GSK, as we share those values of excellence. There is great alignment in these missions and I look forward to our people making a significant contribution to the Olympic Games and Paralympic Games."

30th November 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics